TARA
Protara Therapeutics Inc
NASDAQ: TARA · HEALTHCARE · BIOTECHNOLOGY
$5.33
+3.09% today
Updated 2026-04-30
Market cap
$273.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$3 – $8
Volume
1.0M
Protara Therapeutics Inc (TARA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-31.60%
ROA
-20.60%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-7.97M | — | — | — |
| 2013 | — | $-7.91M | — | — | — |
| 2014 | $2.95M | $-3.34M | 100.00% | -257.12% | -113.36% |
| 2015 | — | $-21.38M | — | — | — |
| 2016 | — | $-28.53M | — | — | — |
| 2017 | — | $-29.96M | — | — | — |
| 2018 | — | $-25.44M | — | — | — |
| 2019 | $0.00 | $-14.99M | — | — | — |
| 2020 | $0.00 | $-33.98M | — | — | — |
| 2021 | $0.00 | $-47.25M | — | — | — |
| 2022 | $0.00 | $-65.95M | — | — | — |
| 2023 | $0.00 | $-40.42M | — | — | — |
| 2024 | $0.00 | $-44.60M | — | — | — |
| 2025 | $0.00 | $-57.44M | — | — | — |